Maternal and Fetal Outcomes in Giant Placental Chorioangioma: A Case Series
International Journal of Drug Delivery Technology · 08.06.2026 · 16 (47s)
DOI: 10.25258/ijddt.16.47s.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.06.2026. Verfasst von KARUTURI SRI RAMYA und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Chorioangioma is the most common benign tumor of the placenta, with an incidence of 0.6–1%. While most are small and asymptomatic, large or highly vascular tumors can cause maternal and fetal complications. This study presents a case series analyzing maternal and fetal outcomes in giant chorioangiomas.
Methods
Five antenatally diagnosed cases of giant chorioangioma which were confirmed by histopathology reports were collected retrospectively over a period of 10 years (2015-2025) in SRIHER which is a tertiary care centre and maternal and fetal outcomes were studied.
Results
The mean maternal age was 27.8 years, and the mean gestational age at delivery was 33.5 weeks. Maternal complications included polyhydramnios, preterm labor, PPROM, and hepatic dysfunction. Fetal complications ranged from anemia and extreme prematurity to hydrops and neonatal death. One fetus required intrauterine transfusion and amnioreduction but succumbed to neonatal death. Another underwent successful percutaneous embolisation at 31 weeks. Three neonates had abdominal circumference >98th centile, and histopathology confirmed chorioangioma in all cases, with infarction, chorioamnionitis, or autoembolisation in some.
Conclusion
Placental chorioangiomas can result in significant maternal and fetal morbidity, with prognosis influenced by tumor size, vascularity and gestational age. Early recognition and tailored management influences the outcomes. This case series signifies the importance of individualized management and multidisciplinary perinatal care in improving maternal and fetal outcomes and also highlights rare maternal associations such as hepatic dysfunction and fetal associations like AC>98%le, that expand the clinical spectrum of the condition.
Zitieren
APA
RAMYA, K. S., G, U. R., & ANDREW, C. (2026). Maternal and Fetal Outcomes in Giant Placental Chorioangioma: A Case Series. International Journal of Drug Delivery Technology, 16(47s). https://doi.org/10.25258/ijddt.16.47s.103
Vancouver
RAMYA KS, G UR, ANDREW C. Maternal and Fetal Outcomes in Giant Placental Chorioangioma: A Case Series. International Journal of Drug Delivery Technology. 2026;16(47s). doi:10.25258/ijddt.16.47s.103
BibTeX
@article{RAMYA2026,
author = {RAMYA, KARUTURI SRI and G, USHA RANI and ANDREW, CHITRA},
title = {Maternal and Fetal Outcomes in Giant Placental Chorioangioma: A Case Series},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {47s},
doi = {10.25258/ijddt.16.47s.103}
}
EUVIMED